The Medtronic RESOLUTE Clinical Trial

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

139

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

June 30, 2007

Study Completion Date

October 31, 2011

Conditions
Coronary Artery Disease
Interventions
DEVICE

Coronary Artery Stenting

Initial implant of drug eluting stent (zotarolimus)

Trial Locations (1)

Unknown

Monash Medical Centre, Melbourne

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Medtronic Vascular

INDUSTRY

NCT00248079 - The Medtronic RESOLUTE Clinical Trial | Biotech Hunter | Biotech Hunter